Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | -1.41% | +6.06% | +4.48% |
Apr. 24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.48% | 348M | |
+24.35% | 653B | |
+25.40% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+12.94% | 233B | |
+5.35% | 201B | |
-9.82% | 193B | |
-6.47% | 144B |
- Stock Market
- Equities
- PGEN Stock
- News Precigen, Inc.
- Insider Trends: Precigen Insider Extends 90-Day Selling Trend